did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9780471939870

Analysing Survival Data from Clinical Trials and Observational Studies

by ;
  • ISBN13:

    9780471939870

  • ISBN10:

    0471939870

  • Edition: 1st
  • Format: Hardcover
  • Copyright: 1995-07-05
  • Publisher: Wiley
  • Purchase Benefits
  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $291.14 Save up to $0.46
  • Buy New
    $290.68
    Add to Cart Free Shipping Icon Free Shipping

    PRINT ON DEMAND: 2-4 WEEKS. THIS ITEM CANNOT BE CANCELLED OR RETURNED.

Supplemental Materials

What is included with this book?

Summary

A practical guide to methods of survival analysis for medical researchers with limited statistical experience. Methods and techniques described range from descriptive and exploratory analysis to multivariate regression methods. Uses illustrative data from actual clinical trials and observational studies to describe methods of analysing and reporting results. Also reviews the features and performance of statistical software available for applying the methods of analysis discussed.

Author Biography

Ettore Marubini is the author of Analysing Survival Data from Clinical Trials and Observational Studies, published by Wiley.

Maria Grazia Valsecchi is the author of Analysing Survival Data from Clinical Trials and Observational Studies, published by Wiley.

Table of Contents

Preface xiii
Series preface xvi
The scope of survival analysis
1(10)
Introduction
1(1)
Characteristics of survival data and problems in survival analysis
2(9)
Characteristics of survival data
2(2)
Censoring
4(3)
Problems in survival analysis
7(4)
Randomized clinical trials: general principles and some controversial issues
11(30)
Introduction
11(3)
Selection of patients and trial design
14(3)
Randomization
17(3)
Statistical inference
20(1)
Randomization and ``intention to treat'' principle
21(3)
Statistical significance and clinical relevance
24(1)
Subset analysis
25(4)
Interim analyses in clinical trials
29(12)
Internal and external monitoring
29(1)
Repeated Significance Testing and early rejection of H0
30(4)
Asymmetric group sequential boundaries and early ``acceptance'' of H0
34(1)
Lan-DeMets procedure
35(1)
Stochastic curtailed sampling
36(1)
Confidence intervals
37(1)
Survivorship data
38(1)
Some caveats
39(1)
Randomization and treatment comparison
39(2)
Estimation of survival probabilities
41(50)
Introduction
41(1)
The product limit estimate
42(6)
Basic concepts
42(4)
Formal definition of the product limit estimate
46(2)
Life tables: fundamentals and construction
48(8)
The life table estimate
49(5)
Comparison of the life table and product limit estimates
54(2)
Measures of precision of the survivorship probability estimates
56(11)
Standard errors and confidence intervals
57(6)
Confidence bands
63(4)
Construction of a survival curve: some comments
67(10)
Definition of the entry point
67(1)
Definition of the end-point
68(2)
Modalities of follow-up
70(4)
Reporting and interpreting a survival curve
74(3)
Event rates
77(14)
Basic concepts
77(1)
Estimate of rates and their standard errors in life tables
78(4)
The relationship between probability and rate
82(3)
The product limit method: theory
85(2)
Delta method
87(1)
Percentiles of the Kolmogorov---Smirnov statistic
88(1)
Critical values for the Hall-Wellner confidence bands
89(2)
Non-parametric methods for the comparison of survival curves
91(52)
Introduction
91(1)
The two sample Mantel-Haenzel (log-rank) test
92(4)
Estimates of the relative hazard rate 0
96(3)
A family of two sample rank tests
99(5)
The inclusion of strata in the Mantel-Haenzel test
104(9)
Formulation of the test statistic
104(3)
Testing homogeneity of treatment effects
107(2)
Gail and Simon test of qualitative interaction
109(4)
Two sample comparison in presence of time-dependent covariates: the Mantel-Byar test
113(10)
Comparison of more than two samples
123(4)
Sample size
127(16)
Hypergeometric distribution
132(1)
Critical values for the Gail and Simon test
133(1)
Freedman's procedure for sample size
134(3)
Sample size according to Freedman
137(6)
Distribution functions for failure time T
143(28)
Introduction
143(1)
T continuous
143(2)
Relationship among f(t), S(t) and λ(t)
145(1)
T discrete
146(2)
Models in survival analysis
148(5)
Specifying a parametric model
148(1)
Estimation of the parameter
149(2)
Variance of the estimator
151(2)
An example
153(1)
Regression models in survival analysis
153(18)
The exponential regression model
154(1)
Estimation of the regression parameters
155(3)
Statistical tests on regression coefficients
158(2)
An example
160(4)
Relationship among LR, Wald and Rao score tests
164(5)
Observed information matrix for the exponential regression model
169(2)
The Cox regression model
171(52)
The basic Cox model
171(8)
Estimation of the regression parameters
179(4)
Estimation of the baseline hazard and survival probability
183(2)
An example
185(8)
Computing estimates
185(4)
Relationship between the score test and the log-rank test
189(4)
The ``implementation'' of the Cox regression model
193(4)
A further example
197(4)
Adjusted survival curves
201(5)
Extensions of the basic Cox model
206(17)
Stratification
206(2)
Time-dependent covariates
208(10)
A family of proportional hazards models
218(2)
Asymptotic variance of Λ0(t) and S0(t)
220(3)
Validation of the proportional hazards models
223(44)
Model selection
223(1)
Graphical methods for checking model assumptions
224(11)
Use of the stratified Cox model
229(6)
Tests on the proportional hazards assumption
235(12)
Test based on defined time-dependent covariates
235(4)
Gill and Schumacher test
239(2)
O'Quigley and Pessione test
241(2)
Tests of proportional hazards against a general alternative
243(2)
Some additional remarks
245(2)
Residuals and regression diagnostics
247(20)
The earlier works
249(2)
Schoenfeld's residuals
251(3)
Martingale based residuals
254(1)
Model criticism in an example
255(12)
Parametric regression models
267(28)
Introduction
267(1)
Some (continuous) distributions of failure time
268(6)
Weibull distribution
268(3)
Gamma distribution
271(1)
Log-normal distribution
272(1)
Log-logistic distribution
272(2)
Parametric regression models
274(6)
Weibull regression model
274(2)
Log-logistic regression model and the class of proportional odds models
276(2)
An example
278(2)
Log-linear regression models for T
280(3)
The class of accelerated failure time (AFT) models
281(2)
Relationship of AFT models with proportional hazards and proportional odds models
283(4)
An example
287(1)
Concluding remarks
288(7)
The gamma function
291(1)
Generation of random failure times from a given distribution
291(1)
Derivation of the linear form in Y = log T for the Weibull distribution
292(3)
The study of prognostic factors and the assessment of treatment effect
295(36)
Introduction
295(1)
Why study prognostic factors?
295(2)
Adjusting the estimate of treatment effect
297(8)
In the presence of unbalanced covariates
297(2)
In the presence of balanced covariates
299(5)
Concluding remarks
304(1)
The study of prognostic factors by means of regression models
305(10)
Problems with usual strategies for variable selection
307(1)
Recommendations and cautions in prognostic factor analysis
308(3)
The predictive value of a prognostic model
311(2)
The definition of risk groups
313(2)
Evaluation of treatment effectiveness
315(16)
Measures suitable for describing clinical trial results
318(2)
Confidence interval of measures of effectiveness
320(6)
Procedures for variable selection
326(1)
Relationship between risk and hazard
327(4)
Competing risks
331(34)
Introduction
331(1)
The product limit estimator in the presence of competing events
332(3)
Cause-specific hazard function, related functions and their estimators
335(3)
Example of computation of crude cumulative incidence
338(1)
Variance of the crude cumulative incidence and an example
339(5)
Latent failure times
344(2)
Cause-specific hazards and prognostic factors
346(7)
Investigation of the relationship between different failure types
353(2)
Comparison of treatment effects
355(2)
Gray's method for comparing crude cumulative incidences
357(8)
Variance of the crude cumulative incidence
361(4)
Meta-analysis
365(18)
Introduction
365(1)
Definition and goals of meta-analysis
365(2)
Fixed effect approach
367(4)
Binary data
369(1)
Survival data
370(1)
Random effect model
371(2)
Examples
373(5)
A promising approach
378(5)
Estimation of σ2y by the method of moments
380(3)
References 383(14)
Author index 397(8)
Subject index 405

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program